- World rank, all time
- #9,644 of 42,892
- Rank in United Kingdom
- #542 of 2,253
- Research works
- 280 ▲ 22% vs 2013–17
- Citations
- 21k 73.6 per fractional work
- Top-10% rate
- 20.9% record average 16.5%
- Open access
- 37% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.5×
- Chemistry 4.4×
- Neuroscience 3.8×
- Biochemistry, Genetics and Molecular Biology 3.4×
- Medicine 2.1×
- Agricultural and Biological Sciences 2.0×
- Immunology and Microbiology 1.6×
- Decision Sciences 1.3×
- Nursing 1.3×
- Materials Science 1.0×
- Health Professions 0.5×
- Computer Science 0.4×
- Business, Management and Accounting 0.4×
- Psychology 0.4×
- Mathematics 0.3×
- Economics, Econometrics and Finance 0.2×
- Physics and Astronomy 0.2×
- Earth and Planetary Sciences 0.1×
- Social Sciences 0.1×
- Engineering 0.0×
Who are the top researchers at GW Pharmaceuticals (United Kingdom)?
Ranked on the composite score, Graeme C.M. Smith, John M. McPartland and Tom D. Heightman lead among researchers whose main affiliation is GW Pharmaceuticals (United Kingdom).
- 1 Graeme C.M. Smith United Kingdom · #113,088 worldwide 336 citations · 23 works
- 2 John M. McPartland United Kingdom · #142,446 worldwide 164 citations · 33 works
- 3 Tom D. Heightman United Kingdom · #302,989 worldwide 158 citations · 16 works
- 4 David L. Norton United Kingdom · #334,790 worldwide 83 citations · 20 works
- 5 Henriëtte M. G. Willems United Kingdom · #592,824 worldwide 75 citations · 15 works
- 6 Christopher N. Johnson United Kingdom · #881,186 worldwide 68 citations · 16 works
Which keywords describe research at GW Pharmaceuticals (United Kingdom)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Neurological Disorders, Cancer Therapy, Cannabinoid Receptors, Endocannabinoid System, Phylogeny, Epilepsy, Taxonomy and DNA Barcoding.
- Invasive Species
- Cognitive Impairment
- Genetics
- DNA Barcoding
- Taxonomy
- Phylogeny
- Endocannabinoid System
- Cancer Therapy
- Neurological Disorders
- Cannabinoid Receptors
- Inflammation
- Epilepsy
- Biodiversity
- Diagnostic Criteria
- Cancer
- Machine Learning
- Evolution
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Neurological Disorders4▲ 24×8 topics
- Cancer Therapy2▲ 12×8 topics
- Cannabinoid Receptors2▲ 201×1 topic
- Endocannabinoid System2▲ 201×1 topic
- Inflammation2▲ 3.2×9 topics
- Phylogeny2▲ 44×5 topics
- Epilepsy2▲ 52×3 topics
- Taxonomy1▲ 40×4 topics
- Biodiversity1▲ 6.6×3 topics
- DNA Barcoding1▲ 30×3 topics
- Diagnostic Criteria1▲ 22×4 topics
- Genetics1▲ 7.0×6 topics
- Cancer1▲ 3.2×5 topics
- Cognitive Impairment1▲ 17×2 topics
- Machine Learning1▲ 1.41×5 topics
- Invasive Species1▲ 9.1×3 topics
- Evolution1▲ 15×2 topics
Which research topics does GW Pharmaceuticals (United Kingdom) publish most on?
By volume in 2022–2025: Cannabis and Cannabinoid Research, Tuberous Sclerosis Complex Research, Lepidoptera: Biology and Taxonomy and Renal Diseases and Glomerulopathies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cannabis and Cannabinoid Research Pharmacology 2 works
- 2 Tuberous Sclerosis Complex Research Physiology 1 works
- 3 Lepidoptera: Biology and Taxonomy Genetics 1 works
- 4 Renal Diseases and Glomerulopathies Nephrology 1 works
- 5 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 1 works
- 6 Cancer-related Molecular Pathways Oncology 0 works
- 7 Gastrointestinal motility and disorders Gastroenterology 0 works
- 8 Calcium signaling and nucleotide metabolism Physiology 0 works
- 9 Amyotrophic Lateral Sclerosis Research Neurology 0 works
- 10 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GW Pharmaceuticals (United Kingdom)'s research output changed?
Output in 2018–2022 was 22% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- University of Cambridge
- Addenbrooke's Hospital
- MRC Laboratory of Molecular Biology
- Anglia Ruskin University
- AstraZeneca (United Kingdom)
- Microsoft Research (United Kingdom)
- British Antarctic Survey
- Cambridge University Hospitals NHS Foundation Trust
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.